Nutraceutical intervention towards wound healing after cancer surgery
- Dr. Anubhab Mukherjee -
A growing knowledge of the physiologic role of various nutritional elements has led to the recognition of certain nutrients like amino acids (glutamine etc.), vitamins (A, C, E, etc.), antioxidants (beta-carotene, coenzyme Q10, etc.), fatty acids (Omega-3. medium-chain triglycerides etc.), trace elements, minerals, etc. in wound management. It is obvious that a higher level of attention and research is required to evaluate the microbial effects on wound-healing ability, potential new therapeutic agents that can regulate the cross-talk between microflora, pathogens and the innate immune response, and lead to wound healing acceleration. Current research has witnessed a major impact of commensal microorganisms, beneficial bacteria, on multiple physiological processes including protection against pathogenic invasion and infection as well as immunomodulatory effects in tissue repair. Of many, Lactic acid bacteria (LAB) and bifidobacteria are some of the most widely studied species that improve host welfare and are most commonly referred to as probiotics.
To this end, Esperer Onco Nutrition (EON) is rejoicing the launch of a new product, namely, Liss WH which is augmented by probiotic blend (Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus fermentum and Bifidobacterium bifidum) having multifarious functions namely, collagen synthesis, H2O2 production, enhanced absorption of dietary vitamin D and E, induction of crucial cytokines (TNFα, IFN-γ, IL-10, etc.), increase in neutrophil infiltration, anti-microbial activity, etc. It is also enriched with natural antioxidants and immuno-nutrients such as β-carotene, coenzyme Q10, and mixed tocopherols which help in the prevention of infections in the surgical wounds, thus speeding up the recovery after cancer surgery. The osmolarity (280 to 300 mosmol /Litre) is suitable for enteral tube feeding and better nutrient absorption. Furthermore, EON intends to extend its research towards exploring nano-nutraceutical intervention for use in surgical wound healing in the recent future. EON believes that the combination of nanotechnology with the existing protocol can pave the way for the future medication of wound management.
About the Author
Dr. Anubhab MukherjeeAuthor & Consultant
Dr. Anubhab Mukherjee, Principal Scientist, R&D in Esperer Onco Nutrition (EON) Pvt. Ltd on Nutraceutical intervention towards wound healing after cancer surgery.
Disclaimer : The views expressed by the author in this feature are entirely her/ his own and do not necessarily reflect the views of INVC NEWS.